Variant report
Variant | nsv431519 |
---|---|
Chromosome Location | chr16:77043478-77091611 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:77044641..77046687-chr16:77049304..77051697,2 | K562 | blood: | |
2 | chr16:77044641..77046687-chr16:77049304..77051697,2 | K562 | blood: | |
3 | chr16:76856883..76857419-chr16:77076804..77077643,2 | MCF-7 | breast: | |
4 | chr16:77076688..77077729-chr16:77203577..77204202,3 | MCF-7 | breast: | |
5 | chr16:77059610..77062396-chr16:77260233..77262257,2 | K562 | blood: | |
6 | chr16:76886880..76887748-chr16:77077328..77078325,2 | MCF-7 | breast: | |
7 | chr16:77078662..77079429-chr16:77203303..77204211,3 | MCF-7 | breast: | |
8 | chr16:76887896..76888842-chr16:77076469..77077719,11 | MCF-7 | breast: | |
9 | chr16:76699528..76700343-chr16:77076632..77077627,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10514407 | chr16:77043478-77043479 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs577806989 | chr16:77043491-77043492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs284922 | chr16:77043517-77043518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs284923 | chr16:77043538-77043539 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs141440683 | chr16:77043549-77043550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114774773 | chr16:77043552-77043553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542262305 | chr16:77043566-77043567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145179412 | chr16:77043572-77043573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185190306 | chr16:77043575-77043576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188507346 | chr16:77043577-77043578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs35830514 | chr16:77043580-77043581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564593116 | chr16:77043616-77043617 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs284924 | chr16:77043626-77043627 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs549939500 | chr16:77043638-77043639 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538950409 | chr16:77043653-77043654 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs8061371 | chr16:77043677-77043678 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs529509335 | chr16:77043698-77043699 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192890129 | chr16:77043699-77043700 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565492982 | chr16:77043709-77043710 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572836825 | chr16:77043734-77043735 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs58736634 | chr16:77043774-77043775 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs185111761 | chr16:77043776-77043777 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189382829 | chr16:77043790-77043791 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145853345 | chr16:77043792-77043793 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542025543 | chr16:77047819-77047820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561688608 | chr16:77047888-77047889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs623615 | chr16:77047901-77047902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs57763273 | chr16:77047907-77047908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564395672 | chr16:77047937-77047938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532584481 | chr16:77047991-77047992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1502445 | chr16:77048642-77048643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371004818 | chr16:77048689-77048690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192301432 | chr16:77048697-77048698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79293280 | chr16:77048754-77048755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140582348 | chr16:77048765-77048766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557318768 | chr16:77049628-77049629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143126781 | chr16:77049641-77049642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377549956 | chr16:77049643-77049644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563770662 | chr16:77049689-77049690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs283996 | chr16:77049696-77049697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535495560 | chr16:77049711-77049712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532684530 | chr16:77049719-77049720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572448639 | chr16:77049724-77049725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs66928751 | chr16:77049761-77049762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs59760585 | chr16:77049802-77049803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112301571 | chr16:77049827-77049828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138010793 | chr16:77049837-77049838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12926690 | chr16:77049840-77049841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74025439 | chr16:77049842-77049843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143006717 | chr16:77049874-77049875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 24585490 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20581869 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:77043000-77043800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr16:77043400-77043600 | Enhancers | Pancreas | Pancrea |
3 | chr16:77043600-77043800 | Bivalent Enhancer | Pancreas | Pancrea |
4 | chr16:77047800-77048000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr16:77048600-77048800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr16:77049600-77058800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr16:77058800-77059000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr16:77062000-77063000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr16:77064800-77065600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr16:77065000-77065400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr16:77065000-77065600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr16:77066000-77066400 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr16:77071400-77072400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr16:77071600-77072400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
15 | chr16:77072000-77072400 | Enhancers | Placenta | Placenta |
16 | chr16:77072000-77073200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr16:77080000-77080600 | Enhancers | Brain Germinal Matrix | brain |
18 | chr16:77082000-77082600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr16:77091200-77097800 | Enhancers | Primary neutrophils fromperipheralblood | blood |